Clinical Trials Logo

Clinical Trial Summary

α-Synucleinopathy is a cluster of neurodegenerative disease with motor and non-motor symptom. The data to be collected is intended to help healthcare providers make important medical decisions concerning α-synucleinopathy, through an enhanced understanding of the natural history, progression and multi-omics datasets of α-synucleinopathy.


Clinical Trial Description

α-Synucleinopathy is a cluster of neurodegenerative disease with motor and non-motor symptom, including Parkinson's disease (PD), multiple system atrophy (MSA) and dementia with lewy bodies (DLB). The data to be collected is intended to help healthcare providers make important medical decisions concerning α-synucleinopathy, through an enhanced understanding of the natural history, progression and multi-omics datasets of α-synucleinopathy. Datas will be accumulated retrospectively at research entry and prospectively during follow up. ;


Study Design


NCT number NCT05527067
Study type Observational [Patient Registry]
Source Fujian Medical University Union Hospital
Contact Xiaodong Pan
Phone 0591-86218341
Email pxd77316@163.com
Status Recruiting
Phase
Start date September 1, 2021
Completion date June 2030